The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users
This study aimed to compare contraceptive efficacy and safety of drospirenone 4 mg in a 24/4-day regimen in nonobese and obese users and describe pharmacokinetics according to bodyweight.
Source: Contraception - Category: OBGYN Authors: Mitchell D. Creinin, Alicyoy Angulo, Enrico Colli, David F. Archer Tags: Original Research Article Source Type: research